Partnerships & Mergers

As part of AAIB’s corporate social responsibility efforts, the system draws on cutting-edge global oncology technology.

Scinai will retain the plant’s entire workforce as it integrates the facility into its CDMO operations.

The partnership seeks to create a more connected, innovation-driven healthcare landscape that aligns with the UAE’s vision for building a diversified, knowledge-based economy.

This initiative aligns with the Universal Health Coverage (UHC) agenda and seeks to transform regional facilities into dependable referral hubs that bring advanced cancer care closer to communities across the country.

The partnership forms a cornerstone of “Plan Mexico,” a government-led economic growth strategy designed to attract investment and develop domestic manufacturing capabilities.

Through this collaboration, they will tackle healthcare projects from multiple angles, offering services that span consulting, strategic planning, feasibility assessments, and market and financial studies.

This initiative demonstrates a shared commitment to advancing preventive and personalized medicine, aligning with the UAE’s growing emphasis on healthspan, wellbeing, and healthcare innovation.

The partnership centers on incorporating Diagnoly’s Fetoly platform into GE HealthCare’s established Voluson women’s health ultrasound systems, marking a significant advancement in prenatal diagnostic technology.

The partnership merges Fujitsu Japan’s deep knowledge of the medical field and cutting-edge technologies, including artificial intelligence, with JMDC’s sophisticated prediction models derived from insurance user data.

Hetronifly is an anti-programmed cell death protein 1 (PD-1) monoclonal antibody that has already received regulatory approval in China for treating several solid tumor types.